Page last updated: 2024-10-24

verapamil and Pleuropericarditis

verapamil has been researched along with Pleuropericarditis in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Pleuropericarditis: Inflammation of both the PERICARDIUM and the PLEURA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prattichizzo, FA1
Simonetti, I1
Galetta, F1

Other Studies

1 other study available for verapamil and Pleuropericarditis

ArticleYear
[Carditis associated with Mycoplasma pneumoniae infection. Clinical aspects and therapeutic problems].
    Minerva cardioangiologica, 1997, Volume: 45, Issue:9

    Topics: Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Dose-

1997